Levothyroxine containing products - Important Safety Information from Amdipharm Limited Ireland and Teva Pharmaceuticals Ireland as approved by the HPRA (20.01.23)

Notice type: 3rd Party Publications

Date: 30/01/2023




Problem Or Issue:

Important Safety Information from Amdipharm Limited Ireland and TEVA Pharmaceuticals Ireland regarding Levothyroxine containing products: Biotin interference with laboratory tests


Important Safety Information – Levothyroxine containing products 


« Back